tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Cash flow

Compare
358 Followers

Keros Therapeutics Cash Flow

KROS's free cash flow for Q3 2025 was $3.12M. For the 2025 fiscal year, KROS's free cash flow was decreased by $-35.83M and operating cash flow was $3.25M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -160.87M$ -124.51M$ -70.06M$ -62.15M$ -36.89M
Investing Cash Flow
$ -1.93M$ -2.46M$ -1.24M$ -1.02M$ -294.00K
Financing Cash Flow
$ 391.82M$ 178.96M$ 120.31M$ 28.55M$ 296.04M
End Cash Position
$ 561.38M$ 332.36M$ 280.38M$ 231.37M$ 265.99M
Free Cash Flow
$ -162.80M$ -126.97M$ -71.30M$ -63.17M$ -37.19M
Currency in USD

Keros Therapeutics Cash Flow